News

When obese diabetic animals (Zucker diabetic fatty rats) were fed large amounts of glucose, the amount of glucose in their blood increased to a higher level, and was

The escalating dose clinical study will evaluate both the safety profile and effects on painful symptoms and analgesic use. In addition, preliminary information regarding the effect of Quadramet

Following a 30-day waiting period after the submission of the investigational new drug (IND) application, ProEthic will begin clinical trials on patients with sports-related, soft-tissue injuries, such as

The new Together Rx Access Card offers savings on a broad range of pharmaceuticals through a free, easy-to-use card. The card will help uninsured Americans who meet income

Results from the phase I trial have been published in the journal, Vaccine. The authors conclude that Vaxin’s novel flu vaccine, which is produced in cell culture, was

The collaboration will combine Targeted Genetics’ adeno-associated virus (AAV) delivery platform with Sirna’s Huntington’s disease (HD) program and knowledge of RNA silencing technologies. The focus of the collaboration

The final analysis of the primary endpoint, time to disease progression, in the D9902A study, did not show a statistically significant delay in time to disease progression in

The R&D collaboration has been established to investigate potential clinical candidates resulting from Acadia’s medicinal chemistry and discovery platform against a broad array of selective muscarinic receptors (receptors

The first approval granted Taxotere (docetaxel), in combination with doxorubicin and cyclophosphamide, for the adjuvant treatment of patients with operable node-positive breast cancer. A second granted Taxotere, in